JNJ Net Margin Lags LLY by 15 Points in Latest Quarters
Johnson & Johnson reports 22% net income margin for Q2 2026, trailing Eli Lilly’s 37% margin from Q1 2026 filings. Johnson & Johnson posted a 22% net income margin for the quarter ended June 28, 2026, reflecting steady but slower profitability growth. The company recently